{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:45:14Z","timestamp":1795160714261,"version":"4.10.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID-19 is characterized by marked variability in clinical severity. Vitamin D had recently been reviewed as one of the factors that may affect the severity in COVID-19. The objective of current study is to analyze the vitamin D level in COVID-19 patients and its impact on the disease severity. After approval from Ethics Committee, M.L.B Medical College the current study was undertaken as continuous prospective observational study of 6\u00a0weeks. Participants were COVID-19 patients of age group 30\u201360\u00a0years admitted during the study period of 6\u00a0weeks. Study included either asymptomatic COVID-19 patients (Group A) or severely ill patients requiring ICU admission (Group B). Serum concentration of 25 (OH)D, were measured along with serum IL-6; TNF\u03b1 and serum ferritin. Standard statistical analysis was performed to analyze the differences. Current Study enrolled 154 patients, 91 in Group A and 63 patients in Group B. The mean level of vitamin D (in ng\/mL) was 27.89\u2009\u00b1\u20096.21 in Group A and 14.35\u2009\u00b1\u20095.79 in Group B, the difference was highly significant. The prevalence of vitamin D deficiency was 32.96% and 96.82% respectively in Group A and Group B. Out of total 154 patients, 90 patients were found to be deficient in vitamin D (Group A: 29; Group B: 61). Serum level of inflammatory markers was found to be higher in vitamin D deficient COVID-19 patients viz. IL-6 level (in pg\/mL) 19.34\u2009\u00b1\u20096.17 vs 12.18\u2009\u00b1\u20094.29; Serum ferritin 319.17\u2009\u00b1\u200938.21\u00a0ng\/mL vs 186.83\u2009\u00b1\u200920.18\u00a0ng\/mL; TNF\u03b1 level (in pg\/mL) 13.26\u2009\u00b1\u20095.64 vs 11.87\u2009\u00b1\u20093.15. The fatality rate was high in vitamin D deficient (21% vs 3.1%). Vitamin D level is markedly low in severe COVID-19 patients. Inflammatory response is high in vitamin D deficient COVID-19 patients. This all translates into increased mortality in vitamin D deficient COVID-19 patients. As per the flexible approach in the current COVID-19 pandemic authors recommend mass administration of vitamin D supplements to population at risk for COVID-19.<\/jats:p>","DOI":"10.1038\/s41598-020-77093-z","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T11:03:51Z","timestamp":1605783831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":238,"title":["Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers"],"prefix":"10.1038","volume":"10","author":[{"given":"Anshul","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra Singh","family":"Sengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Mahor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Narain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"77093_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5 (2020).","journal-title":"Lancet"},{"issue":"10223","key":"77093_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223), 507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7 (2020).","journal-title":"Lancet"},{"key":"77093_CR3","unstructured":"WHO Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. (2020). https:\/\/www.who.int\/internal-publications-detail\/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected."},{"key":"77093_CR4","unstructured":"Notice of the National Health Commission of the People\u2019s Republic of China on revising the English name of novel coronavirus pneumonia (2020) https:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202002\/33393aa53d984ccdb1053a52b6bef810.shtml. Accessed 29 Feb 2020 (in Chinese)."},{"key":"77093_CR5","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard Data last updated:\u00a02020\/8\/12, 3:41pm CEST. https:\/\/covid19.who.int\/WHO-COVID-19-global-data.csv. Accessed 13 Aug 2020."},{"key":"77093_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","author":"Z Wu","year":"2020","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u202f314 cases from the Chinese center for disease control and prevention. JAMA https:\/\/doi.org\/10.1001\/jama.2020.2648 (2020).","journal-title":"JAMA"},{"key":"77093_CR7","doi-asserted-by":"publisher","first-page":"154217","DOI":"10.1016\/j.metabol.2020.154217","volume":"107","author":"MA Hill","year":"2020","unstructured":"Hill, M. A., Mantzoros, C. & Sowers, J. R. Commentary: COVID-19 in patients with diabetes. Metabolism. 107, 154217. https:\/\/doi.org\/10.1016\/j.metabol.2020.154217 (2020).","journal-title":"Metabolism."},{"key":"77093_CR8","volume-title":"Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium","year":"2011","unstructured":"Ross, A. C., Taylor, C. L., Yaktine, A. L. et al. (eds) Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium (National Academies Press, Washington, DC, 2011)."},{"issue":"1","key":"77093_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/nu5010111","volume":"5","author":"M Wacker","year":"2013","unstructured":"Wacker, M. & Holick, M. F. Vitamin D: effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 5(1), 111\u2013148. https:\/\/doi.org\/10.3390\/nu5010111 (2013).","journal-title":"Nutrients."},{"issue":"7","key":"77093_CR10","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline [published correction appears in [J Clin Endocrinol Metab 2011;96(12):3908]. J. Clin. Endocrinol. Metab. 96(7), 1911\u20131930. https:\/\/doi.org\/10.1210\/jc.2011-0385 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"77093_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nefro.2018.07.004","volume":"39","author":"MP Cardoso","year":"2019","unstructured":"Cardoso, M. P. & Pereira, L. A. L. Native vitamin D in pre-dialysis chronic kidney disease. Nefrologia. 39(1), 18\u201328. https:\/\/doi.org\/10.1016\/j.nefro.2018.07.004 (2019).","journal-title":"Nefrologia."},{"issue":"3","key":"77093_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle, D. D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 21(3), 319\u2013329. https:\/\/doi.org\/10.1016\/j.chembiol.2013.12.016 (2014).","journal-title":"Chem. Biol."},{"issue":"1","key":"77093_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2249.2009.04001.x","volume":"158","author":"DA Hughes","year":"2009","unstructured":"Hughes, D. A. & Norton, R. Vitamin D and respiratory health. Clin. Exp. Immunol. 158(1), 20\u201325. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.04001.x (2009).","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"77093_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4103\/jfmpc.jfmpc_78_18","volume":"7","author":"P Aparna","year":"2018","unstructured":"Aparna, P., Muthathal, S., Nongkynrih, B. & Gupta, S. K. Vitamin D deficiency in India. J. Family Med. Prim. Care. 7(2), 324\u2013330. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_78_18 (2018).","journal-title":"J. Family Med. Prim. Care."},{"issue":"1","key":"77093_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4065\/mcp.2010.0567","volume":"86","author":"TD Thacher","year":"2011","unstructured":"Thacher, T. D. & Clarke, B. L. Vitamin D insufficiency. Mayo Clin. Proc. 86(1), 50\u201360. https:\/\/doi.org\/10.4065\/mcp.2010.0567 (2011).","journal-title":"Mayo Clin. Proc."},{"key":"77093_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.07.001","author":"KV Argyropoulos","year":"2020","unstructured":"Argyropoulos, K. V. et al. Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms. Am. J. Pathol. https:\/\/doi.org\/10.1016\/j.ajpath.2020.07.001 (2020).","journal-title":"Am. J. Pathol."},{"issue":"9","key":"77093_CR17","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s00277-020-04169-1","volume":"99","author":"CA Latz","year":"2020","unstructured":"Latz, C. A. et al. Blood type and outcomes in patients with COVID-19. Ann. Hematol. 99(9), 2113\u20132118. https:\/\/doi.org\/10.1007\/s00277-020-04169-1 (2020).","journal-title":"Ann. Hematol."},{"key":"77093_CR18","volume-title":"Features, Evaluation and Treatment Coronavirus (COVID-19)","author":"M Cascella","year":"2020","unstructured":"Cascella, M. et al. Features, Evaluation and Treatment Coronavirus (COVID-19) (StatPearls Publishing, Treasure Island, 2020)."},{"key":"77093_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","volume":"53","author":"SH Nile","year":"2020","unstructured":"Nile, S. H. et al. COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 53, 66\u201370. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.002 (2020).","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"77093_CR20","first-page":"95","volume":"22","author":"F Ciceri","year":"2020","unstructured":"Ciceri, F. et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit. Care Resusc. 22(2), 95\u201397 (2020).","journal-title":"Crit. Care Resusc."},{"issue":"2","key":"77093_CR21","doi-asserted-by":"publisher","first-page":"100029","DOI":"10.1016\/j.cytox.2020.100029","volume":"2","author":"G Magro","year":"2020","unstructured":"Magro, G. SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the \u201cculprit lesion\u201d of ARDS onset? What is there besides Tocilizumab?. Cytokine X. 2(2), 100029. https:\/\/doi.org\/10.1016\/j.cytox.2020.100029 (2020).","journal-title":"Cytokine X."},{"issue":"12","key":"77093_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones, S. A. & Jenkins, B. J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat. Rev. Immunol. 18(12), 773\u2013789. https:\/\/doi.org\/10.1038\/s41577-018-0066-7 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"77093_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448\u2013457 (2015).","journal-title":"Nat. Immunol."},{"key":"77093_CR24","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/nu5072502","volume":"5","author":"B Prietl","year":"2013","unstructured":"Prietl, B., Treiber, G., Piber, T. R. & Amrein, K. Vitamin D and immune function. Nutrients. 5, 2502\u20132521 (2013).","journal-title":"Nutrients."},{"key":"77093_CR25","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1136\/bmj.i6583","volume":"356","author":"AR Martineau","year":"2017","unstructured":"Martineau, A. R. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 356, 6583\u20136594 (2017).","journal-title":"BMJ"},{"issue":"1","key":"77093_CR26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/nu12010236","volume":"12","author":"AF Gombart","year":"2020","unstructured":"Gombart, A. F., Pierre, A. & Maggini, S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 12(1), 236. https:\/\/doi.org\/10.3390\/nu12010236 (2020).","journal-title":"Nutrients."},{"key":"77093_CR27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","volume":"10","author":"F Baeke","year":"2010","unstructured":"Baeke, F., Takiishi, T. & Korf, H. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10, 482\u2013496 (2010).","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"77093_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4103\/ijmr.IJMR_1807_18","volume":"148","author":"P Kamboj","year":"2018","unstructured":"Kamboj, P., Dwivedi, S. & Toteja, G. S. Prevalence of hypovitaminosis D in India & way forward. Indian J. Med. Res. 148(5), 548\u2013556. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1807_18 (2018).","journal-title":"Indian J. Med. Res."},{"issue":"5","key":"77093_CR29","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.3892\/mmr.2017.7546","volume":"16","author":"J Xu","year":"2017","unstructured":"Xu, J. et al. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol. Med. Rep. 16(5), 7432\u20137438. https:\/\/doi.org\/10.3892\/mmr.2017.7546 (2017).","journal-title":"Mol. Med. Rep."},{"key":"77093_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nfs.2020.06.001","volume":"20","author":"HK Biesalski","year":"2020","unstructured":"Biesalski, H. K. Vitamin D deficiency and co-morbidities in COVID-19 patients: a fatal relationship?. Nfs J. 20, 10\u201321. https:\/\/doi.org\/10.1016\/j.nfs.2020.06.001 (2020).","journal-title":"Nfs J."},{"issue":"5","key":"77093_CR31","first-page":"81","volume":"113","author":"E Laird","year":"2020","unstructured":"Laird, E., Rhodes, J. & Kenny, R. A. Vitamin D and inflammation: potential implications for severity of covid-19. Ir. Med. J. 113(5), 81 (2020).","journal-title":"Ir. Med. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77093-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77093-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77093-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:25:14Z","timestamp":1670369114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77093-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77093"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77093-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"21 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20191"}}